If you are evaluating a prescription drug pricing database, the hard part is not finding a page with prices. The hard part is figuring out whether the tool will actually support reimbursement analysis, sourcing decisions, manufacturer comparison, and repeat monitoring once your team starts using it in production.
That is a different problem from a basic drug-price lookup. This guide is for teams comparing pricing tools, data vendors, or internal build paths and trying to decide what a database must do before they commit time or budget.
Tip
If you want to test this checklist against a live workflow, start with drug search, compare Drug Markets, review Manufacturers, or inspect the platform's API Docs.
Who This Guide Is For
This guide is most useful for:
- ●Pharmacy reimbursement and contracting teams
- ●Pharmacy buyers and sourcing analysts
- ●Medicaid and policy researchers
- ●Consultants evaluating drug-pricing tools for clients
- ●Product teams deciding whether a pricing API or database is worth integrating
If you are just trying to look up a current price or compare one drug market, start with Drug Pricing Database. That article is the broader search-and-lookup overview. This one is about tool evaluation.
Evaluation Criteria That Actually Matter
The right prescription drug pricing database should help you answer operational questions such as:
- ●Can we get to the exact NDC without product mismatches?
- ●Can we compare manufacturers across the full market, not just one package?
- ●Is the benchmark clearly defined and appropriate for reimbursement work?
- ●Does the system include historical data, alerts, exports, or API access?
Those are the questions that separate a real working database from a generic content page with a few prices on it.
1. NDC coverage and normalization
The first thing to verify is whether the database handles NDC-level detail correctly. A serious workflow depends on the exact product, not just the drug name.
You should be able to tell whether the system can distinguish between:
- ●Different manufacturers of the same generic
- ●Different package sizes
- ●Different dosage forms or strengths
- ●Brand and generic versions of the same molecule
If the platform is weak here, every downstream analysis gets weaker too.
2. Market grouping and manufacturer comparison
Many pricing questions start with one NDC but quickly become market questions. A good database should let you move from a single product into the full market around that molecule.
That means it should support clean views for Drug Markets and Manufacturers, not just isolated product pages.
3. Benchmark clarity
The number is only useful if the benchmark is clearly defined. You should know whether the system is using NADAC, AWP, WAC, MAC, or another reference and what that means for the decisions you are making.
If benchmark choice is central to your workflow, read Understanding NADAC Pricing, NADAC vs AWP, NADAC vs WAC, and Pharmacy Reimbursement Benchmark.
4. Historical depth and trend coverage
A database that only shows current values is often not enough. Teams usually need to know whether the price has been stable, whether a market is tightening, or whether a category is showing unusual movement.
That is why a useful tool should expose history and trend surfaces such as Trends and Therapeutic Classes, not just a single current-price result.
5. Workflow features beyond lookup
If the use case is recurring, the evaluation should go beyond the data model. Ask whether the platform supports:
- ●Alerts
- ●Repeat monitoring
- ●Exports
- ●Role-based use by a team
- ●Programmatic access
This is often the difference between a one-time research tool and a system the team can actually operationalize.
6. API and export readiness
If your team expects to integrate the data into an internal workflow, the database should have a clear path to exports or API access.
If that is part of the buying decision, review Drug Pricing API alongside the product's API Docs.
Questions to Ask Before You Buy or Build
Before choosing a prescription drug pricing database, ask:
- ●Can we get from one NDC to the full market quickly?
- ●Does the system expose manufacturer comparison cleanly?
- ●Is the benchmark appropriate for reimbursement work?
- ●How much historical depth is available?
- ●Can we monitor weekly movement without manual rework?
- ●Are exports or an API available if this becomes a repeat workflow?
These questions are especially important if your alternative is building an internal solution from raw NADAC files. The database should save enough workflow friction to justify itself.
Red Flags During Evaluation
Common warning signs include:
- ●Drug-name search without reliable NDC precision
- ●No way to expand from a product into the broader market
- ●Benchmark ambiguity or vague benchmark language
- ●No historical series or weak trend coverage
- ●No export or API path for recurring work
- ●Content-heavy positioning with little evidence of actual workflow depth
How NADAC Intelligence Fits This Checklist
NADAC Intelligence is strongest when the evaluation criteria above matter to you. It gives you:
- ●Direct search by NDC or product name
- ●Drug Markets for molecule-level comparison
- ●Manufacturers for supplier analysis
- ●Therapeutic Classes and Trends for broader movement screens
- ●Pricing and API Docs when the use case becomes operational
If your team is evaluating tools rather than just researching pricing concepts, this is the more relevant path than the broader Drug Pricing Database overview.
Frequently Asked Questions
What should a prescription drug pricing database do beyond price lookup?
It should support NDC precision, market grouping, manufacturer comparison, historical analysis, and a path to monitoring or integration.
How is this different from a general drug pricing database article?
This guide is about evaluating the tool itself. Our Drug Pricing Database guide is the broader overview for search and lookup workflows.
Is NADAC enough by itself?
NADAC is a strong public benchmark for many reimbursement and acquisition-cost workflows, but a usable database also needs clean product structure, history, and workflow features.
When does API access matter?
API access matters when the team needs repeat monitoring, reporting, or internal product integration instead of one-off manual lookups.
Final Takeaway
A prescription drug pricing database is worth adopting only if it supports the workflow around the price, not just the price itself. That means NDC accuracy, market structure, benchmark clarity, historical depth, and an operational path for repeat use.
Use this checklist to evaluate whether a platform can support reimbursement analysis in practice, then test the workflow in NADAC Intelligence through search, Drug Markets, Manufacturers, Trends, Pricing, and API Docs.